Literature DB >> 27566448

Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study.

George Boon-Bee Goh1,2, An Pan3,4, Wan-Cheng Chow1,2, Jian-Min Yuan5,6, Woon-Puay Koh2,7.   

Abstract

BACKGROUND & AIM: Diabetes mellitus has been linked to cirrhosis-related mortality in Western populations, but less is known about this relationship in Asian populations. We studied the impact of diabetes on the risk of cirrhosis mortality in a population-based cohort among Chinese in Singapore.
METHODS: We used data collected and analysed from the Singapore Chinese Health Study, a prospective community-based cohort of 63 275 subjects aged 45-74 years during enrolment between 1993 and 1998. Information on diet, lifestyle and medical history was collected via structured questionnaire. Mortality cases from cirrhosis in the cohort were identified via linkage with nationwide death registry up to 31 December 2014. Cox proportional regression models were used to estimate the associations with adjustment for risk factors of cirrhosis.
RESULTS: After a mean follow-up of 16.9 years, there were 133 deaths from cirrhosis. Diabetes was associated with an increased risk of cirrhosis mortality (hazard ratio [HR]: 2.80; 95% confidence interval [CI]: 2.04-3.83), and for both viral (HR: 2.20; 95% CI: 1.18-4.11) and non-viral hepatitis-related cirrhosis mortality (HR: 3.06; 95% CI: 2.13-4.41). The association between diabetes and non-viral hepatitis-related cirrhosis mortality was stronger among participants of body mass index (BMI) less than 23 kg/m2 (HR: 7.11; 95% CI: 3.42-14.79) compared to heavier individuals (HR: 2.28; 95% CI: 1.20-4.35) (Pinteraction =0.02).
CONCLUSION: Diabetes is a risk factor for cirrhosis mortality, especially for non-viral hepatitis-related cirrhosis in population with BMI considered low or normal in Asia.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Singapore; body mass index; cirrhosis mortality; diabetes mellitus

Mesh:

Year:  2016        PMID: 27566448      PMCID: PMC5225025          DOI: 10.1111/liv.13241

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  42 in total

1.  Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.

Authors:  Timothy M E Davis; Kirsten E Peters; David G Bruce; Wendy A Davis
Journal:  J Clin Endocrinol Metab       Date:  2012-02-22       Impact factor: 5.958

2.  Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study.

Authors:  Chiara Giordanino; Simone Ceretto; Simona Bo; Antonina Smedile; Alessia Ciancio; Elisabetta Bugianesi; Rinaldo Pellicano; Sharmila Fagoonee; Elisabetta Versino; Giuseppe Costa; Daniele Arese; Marco Sacco; Mario Rizzetto; Giorgio Saracco
Journal:  Dig Liver Dis       Date:  2012-01-14       Impact factor: 4.088

3.  Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis.

Authors:  Tsutomu Nishida; Shingo Tsuji; Masahiko Tsujii; Shoko Arimitsu; Yoshimichi Haruna; Eiichi Imano; Masaaki Suzuki; Tsutomu Kanda; Sunao Kawano; Naoki Hiramatsu; Norio Hayashi; Masatsugu Hori
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

Review 4.  Epidemiology of hepatitis B and C viruses: a global overview.

Authors:  Helen S Te; Donald M Jensen
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

5.  Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study.

Authors:  Andrew O Odegaard; Mark A Pereira; Woon-Puay Koh; Kazuko Arakawa; Hin-Peng Lee; Mimi C Yu
Journal:  Am J Clin Nutr       Date:  2008-10       Impact factor: 7.045

6.  Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Claudia O Zein; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2009-11       Impact factor: 6.126

7.  Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study.

Authors:  Yi-Wen Huang; Sien-Sing Yang; Szu-Chieh Fu; Ting-Chuan Wang; Cheng-Kai Hsu; Ding-Shinn Chen; Jui-Ting Hu; Jia-Horng Kao
Journal:  Hepatology       Date:  2014-07-17       Impact factor: 17.425

8.  Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies.

Authors:  A Katrina Loomis; Shaum Kabadi; David Preiss; Craig Hyde; Vinicius Bonato; Matthew St Louis; Jigar Desai; Jason M R Gill; Paul Welsh; Dawn Waterworth; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2015-12-16       Impact factor: 5.958

9.  Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities.

Authors:  Marcello Persico; Mario Masarone; Vincenzo La Mura; Eliana Persico; Francesco Moschella; Monica Svelto; Savino Bruno; Roberto Torella
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

View more
  7 in total

1.  Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Iain Turnbull; Yu Guo; Robert Clarke; Yiping Chen; Fiona Bragg; Ling Yang; Zheng Bian; Iona Y Millwood; Juanzhi Hao; Xianyong Han; Yajing Zang; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Hepatology       Date:  2018-10       Impact factor: 17.425

2.  Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.

Authors:  Helen Jarvis; Dawn Craig; Robert Barker; Gemma Spiers; Daniel Stow; Quentin M Anstee; Barbara Hanratty
Journal:  PLoS Med       Date:  2020-04-30       Impact factor: 11.069

3.  Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study.

Authors:  Zhaohui Bai; Bimin Li; Su Lin; Bang Liu; Yiling Li; Qiang Zhu; Yunhai Wu; Yida Yang; Shanhong Tang; Fanping Meng; Yu Chen; Shanshan Yuan; Lichun Shao; Xingshun Qi
Journal:  Adv Ther       Date:  2019-09-11       Impact factor: 3.845

4.  Hepatointestinal complications in polycystic kidney disease.

Authors:  Shih-Ting Huang; Ya-Wen Chuang; Tung-Min Yu; Cheng-Li Lin; Long-Bin Jeng
Journal:  Oncotarget       Date:  2017-09-15

5.  Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis.

Authors:  Tatsunori Hanai; Makoto Shiraki; Kenji Imai; Atsushi Suetsugu; Koji Takai; Masahito Shimizu
Journal:  J Clin Med       Date:  2020-04-03       Impact factor: 4.241

6.  Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis.

Authors:  Sang Bong Ahn; Elizabeth E Powell; Anthony Russell; Gunter Hartel; Katharine M Irvine; Chris Moser; Patricia C Valery
Journal:  Hepatol Commun       Date:  2020-06-30

7.  Type 2 Diabetes, PNPLA3 rs738409 Polymorphism, and the Risk of Liver Cirrhosis: Analysis of Taiwan Biobank.

Authors:  Kuan-Chun Hsueh; Oswald Ndi Nfor; Shu-Yi Hsu; Shun-Fa Yang; Yung-Po Liaw
Journal:  Front Genet       Date:  2022-03-07       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.